Price
No data yet.
Social Signal Score
Analyst Ratings
29 analystsRevenue
$249.56M+303.89%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Richard K. Matros
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Employees
- 58
- Beta
- 0.64
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 0.97
Financials
Revenue
$249.56M+303.9%Net Income
$28.61M+38.8%EBITDA
$122.57M+127.3%Free Cash Flow
$113.07M+163.4%EPS (diluted)
$0.11-64.5%Shares Outstanding (diluted)
259.82M+295.6%Operating Expenses
$15.58MCash & Debt
$36.24MReturn of Capital
$76.64MRevenue by Segment (annual)
$4.90MDividend per Share
$0.30Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $774.63M | $155.61M | $0.64 |
| 2024 | $703.24M | $126.71M | $0.54 |
| 2023 | $647.51M | $13.76M | $0.06 |
| 2022 | $624.81M | $-77.61M | $-0.34 |
| 2021 | $569.54M | $-113.26M | $-0.52 |
| 2020 | $598.57M | $138.42M | $0.67 |
| 2019 | $668.18M | $69.00M | $0.37 |
| 2018 | $623.41M | $279.08M | $1.57 |
| 2017 | $405.65M | $158.38M | $1.40 |
| 2016 | $260.53M | $70.28M | $0.92 |
| 2015 | $238.86M | $79.41M | $1.11 |
| 2014 | $183.52M | $46.95M | $0.79 |
| 2013 | $134.78M | $33.72M | $0.69 |
| 2012 | $103.17M | $19.51M | $0.53 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from SBRA's reported EPS growth of 1.5% a year over 13 years.
- EPS in 5 years
- $0.69
- Implied price
- $20.84
- Return from $21.47
- -0.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $10.36 — -51.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 20 | 25 | 30 | 35 | 40 |
|---|---|---|---|---|---|
| -8.5% | -17.4% | -13.6% | -10.4% | -7.6% | -5.1% |
| -3.5% | -12.9% | -8.9% | -5.5% | -2.5% | 0.1% |
| 1.5% | -8.3% | -4.2% | -0.6% | 2.5% | 5.3% |
| 6.5% | -3.8% | 0.6% | 4.3% | 7.6% | 10.5% |
| 11.5% | 0.7% | 5.3% | 9.2% | 12.6% | 15.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
170+142.86%Social Signal Score
Mentions (11)
- News (RSS)aljazeera·11d ago·Positive
Scenes show aftermath of horrific Israeli strike on Gaza tents Palestinian families have returned to the Sabra neighbourhood of Gaza City after an Israeli strike killed three people.
View source ↗ - News (RSS)seekingalpha·11d ago·Positive
Sabra Health Care REIT Is A Buy After Q3 Shows More Portfolio Expansion
View source ↗ - Newsseekingalpha.com·11d ago·Positive
Sabra Health Care REIT Is A Buy After Q3 Shows More Portfolio Expansion SBRA gets prior buy rating reaffirmed, agreeing with consensus today from Wall St, analysts, and quant rating. Positives continue to be the senior tailwind, dividend coverage, portfolio growth, and investment-grade rating. Upside and FFO forecasts are more modest now, but remain positive.
View source ↗ - News (RSS)fool·18d ago·Positive
Sabra Health Care: 3 Key Takeaways for Long-Term Investors Lease resets on its skilled nursing properties could lift cash rents, but the portfolio shift toward senior housing brings operating risk.
View source ↗ - Newsfool.com·18d ago·Positive
Sabra Health Care: 3 Key Takeaways for Long-Term Investors Sabra raised its full-year normalized FFO guidance midpoint by $0.005 per share. Third-quarter same-store senior housing operating portfolio occupancy reached 89.2%.
View source ↗ - Newsmarketbeat.com·19d ago·Neutral
What Sabra Healthcare REIT (SBRA) Said on Its Q3 Earnings Call Sabra Healthcare REIT NASDAQ: SBRA reported higher third-quarter normalized funds from operations and continued growth in its senior housing operating portfolio, while management said it remains focused on expanding its SHOP exposure and optimizing rents across portions of its skilled nursing portfolio.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Sabra Health Care REIT, Inc. (SBRA) Q3 2026 Earnings Call Transcript Sabra Health Care REIT, Inc. ( SBRA ) Q3 2026 Earnings Call November 3, 2026 1:00 PM EST Company Participants Lukas Hartwich - Executive Vice President of Finance Rick Matros - Chairman, President & CEO Darrin Smith - Chief Investment Officer, Secretary & Executive VP Michael Costa - Executive VP, CFO & Treasurer Conference Call Participants Juan Sanabria - BMO Capital Markets Equity Research James Feldman - Wells Fargo Securit…
View source ↗ - News (Marketaux)gurufocus.com·34d ago·Positive
SBRA Maintained by Wells Fargo -- Price Target Lowered to $21.00 Analyst Rating Update: Sabra <e[+366 characters]
View source ↗ - News (RSS)aljazeera·44d ago·Positive
A father’s agony after an Israeli air strike hits Gaza apartment An Israeli air strike hit a building in Gaza City’s al-Sabra neighbourhood, killing several people, including children.
View source ↗ - News (RSS)seekingalpha·67d ago·Neutral
Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting Started
View source ↗ - Newsseekingalpha.com·67d ago·Positive
Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting Started Sabra Health Care REIT remains a Buy, supported by improving fundamentals and an attractive valuation amid a strategic pivot to managed senior housing. SBRA reported Q2 2026 normalized AFFO of $0.40 per share, a ~5% YoY increase, with occupancy rising to 85.4% and guidance reaffirmed. Significant investments—$599 million YTD at ~7.5% yield—position SBRA for the Silver Tsunami, despite near-term macro and rate headwinds.
View source ↗
Earnings
Thu, Feb 11(in 3 months)
Consensus estimate $0.17 per share
Typical surprise -32.8% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 2$0.11 vs $0.16miss
- Mon, Aug 3$-0.10 vs $0.17miss
- Wed, Apr 29$0.16 vs $0.17miss
- Thu, Feb 12$0.11 vs $0.17miss
- Wed, Nov 5$0.09 vs $0.18miss
- Mon, Aug 4$0.28 vs $0.18beat
Estimates and results for SBRA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SBRA officers and directors.
- Bought
- —
- Sold
- $4.5m
0 trades
2 trades
- Matros Richard Ksold
- Flores Jessicasold
98 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Daniel Goldmanhouse · NY10 · disclosed May 19, 2023 (39d later)Sell$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Apr 17, 2023 (47d later)Buy$1,001 - $15,000
- Chris Jacobshouse · NY27 · disclosed Dec 12, 2022 (34d later)Sell$1,001 - $15,000
- Lois Frankelhouse · FL21 · disclosed Mar 27, 2019 (19d later)Sell$1,001 - $15,000
- Lois Frankelhouse · FL21 · disclosed Mar 27, 2019 (16d later)Sell$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Jan 23, 2019 (33d later)Buy$50,001 - $100,000
- Gary James Palmerhouse · AL06 · disclosed Sep 29, 2018 (54d later)Buy$1,001 - $15,000
- Gary James Palmerhouse · AL06 · disclosed Sep 29, 2018 (79d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
